Screener
Kyverna Therapeutics, Inc. KYTX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $521.73M.
The source filing: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219397
FAQ
- What is Kyverna Therapeutics, Inc.'s market capitalization?
- Kyverna Therapeutics, Inc. (KYTX) reported market capitalization of $521.73M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s market capitalization changed year-over-year?
- Kyverna Therapeutics, Inc.'s market capitalization increased by 526.2% year-over-year, from $83.32M to $521.73M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Kyverna Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude